A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
Our algorithm has found invalid data in this filing
Sym
Weight
Trade Impact
Company
Class
Shares Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
David Caplan
Vice President and General Counsel
New York,, New York
11/16/2023
Per the guidance provided in Special Instruction 4: The Form 13F Combination Report for Atairos Partners GP, Inc., with Accession No. 0000950103-23-013333 and a 03/31/2022 reporting period, should have been filed with a 03/31/2023 reporting period. This Amendment is being filed solely to clarify this typographical error, and all other material presented in this Amended Form 13F Combination Report should be read to apply to a 03/31/2023 reporting period.
List of Other Managers Reporting for Atairos Partners GP, Inc.:
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.